Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Nutranomics, Inc.
DRAPER, Utah, Oct.16, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that following up his successful business trip to Manila in late September, Company CEO Dr. Tracy K. Gibbs has secured a purchase order from a health food supplement distribution company in the Philippines. The initial purchase order for $89,000 includes six newly developed products from Nutranomics.
"Not only will this client be adding six new Nutranomics products to their distribution network, but the really good news for their more than 25,000 distributors is that the new products are already registered with the Philippines' equivalent of the FDA, the BFAD," commented Dr. Tracy K. Gibbs. "We expect that the new products will be available across their distribution network shortly."
In addition to providing the Company with an initial purchase order, the client has also requested that Nutranomics develop up to six new products for their exclusive distribution in the Philippines.
"On top of the initial purchase order and ongoing potential re-orders from the client, they also requested that we utilize our new product development expertise to design six new products exclusive for their lineup. I have no doubt that this shows that we are continuing to satisfy our customers' needs and that our Asian expansion is headed in the right direction. I look forward to announcing the release of these new products in the future," concluded Dr. Gibbs.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at email@example.com or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements". Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, developing six new products and increasing sales of Nutranomics products to the client. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.
©2012 PR Newswire. All Rights Reserved.